China Shineway Pharmaceutical Group Limited (HKG:2877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.85
+0.07 (0.72%)
Apr 29, 2026, 4:08 PM HKT
27.26%
Market Cap 7.39B
Revenue (ttm) 3.49B
Net Income (ttm) 1.06B
Shares Out 755.40M
EPS (ttm) 1.40
PE Ratio 6.99
Forward PE 6.75
Dividend 0.54 (5.51%)
Ex-Dividend Date May 4, 2026
Volume 896,756
Average Volume 1,536,264
Open 9.62
Previous Close 9.78
Day's Range 9.62 - 9.92
52-Week Range 6.96 - 10.47
Beta 0.84
RSI 53.80
Earnings Date Mar 27, 2026

About HKG:2877

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Sector Healthcare
Founded 2002
Employees 2,867
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2877
Full Company Profile

Financial Performance

In 2025, HKG:2877's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.